Alcon ups ante in takeover battle with Novartis

, Comments 0 comments

A longstanding feud between eye-care company, Alcon, and Swiss pharma giant, Novartis, edges towards the court room as Alcon creates a 50 million dollar legal expenses fund. Alcon directors intend to fight Novartis to win a higher price for their shares while the trading community follows the saga to try and profit from stock movements.

0 Comments To This Article